PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50126F61002Rtor bio-amt-2312: assessment of the therapeutic — Lovelace Biomedical Research Institute

Lovelace Biomedical Research Institute holds $30.2M across 54 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 2 related awards under parent 75A50122D00021. Recompete timing centers on the Apr 25, 2028 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma
Awarding office
Lovelace Biomedical Research Institute
Recipient
Apr 25, 2028
PoP end
$3.7M
Obligated
$3.7M
Potential
541714
NAICS
AN13
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract number75A50126F61002
Also listed as75A50122D00021-75A50126F61002
AgencyBarda - Aspr / Daappo / Barda Dcma
Awarding officeBarda - Aspr / Daappo / Barda Dcma
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentLovelace Biomedical Research Institute
CAGE3MMH4
UEIMBT9RXJJ7428
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN13
Parent IDIQ / IDV75A50122D00021
Place of performanceALBUQUERQUE NM
Pricing typeCost Plus Fixed Fee
Extent competedFull And Open Competition
Related solicitationRTOR-BIO-AMT-2312
PoP startAug 26, 2026
PoP end (current)Apr 25, 2028
Obligated$3.7M
Current value$3.7M
Potential value$3.7M

Rtor Bio-Amt-2312: Assessment of the Therapeutic Potential of Chloroquine and Oseltamivir in Two (2) Lethal Models of I… is a federal award for Barda - Aspr / Daappo / Barda Dcma held by Lovelace Biomedical Research Institute. Estimated value $3.7M ($3.7M obligated). Current period of performance ends Apr 25, 2028. Place of performance: ALBUQUERQUE NM. Related solicitation RTOR-BIO-AMT-2312.

Rtor bio-amt-2312: assessment of the therapeutic potential of chloroquine and oseltamivir in two (2) lethal models of influenza a h5n1

Recompete timing

Public
● Expiring in 556 days

Current PoP ends Apr 25, 2028 (556 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Oct 25, 2026.

Want the durability read on 75A50126F61002? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Lovelace Biomedical Research Institute — $30.2M obligated across 54 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($30.2M) · all agencies
Department of Health and Human Services (HHS)$29.7M · 98%Department of Defense (DOD)$486K · 2%
Open full company profile →

Related awards

Same parent · incumbent
W81XWH22P0157
LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.
$742K
Sep 22, 2027
75F40125P00216
SOLE SOURCE AWARD OF A 24-MONTH PERIOD, FIRM FIXED PRICE (FFP), ENDS TOXICOLOGICAL STUDIES…
$7.1M
Sep 29, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50126F61002?

75A50126F61002 (Rtor bio-amt-2312: assessment of the therapeutic) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $3.7M, currently held by Lovelace Biomedical Research Institute. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50126F61002?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50126F61002 to Lovelace Biomedical Research Institute (potential $3.7M).

Who is the incumbent on 75A50126F61002?

Lovelace Biomedical Research Institute is the incumbent with $30.2M across 54 related awards in SCOUT’s public footprint. The current period of performance ends Apr 25, 2028.

When does Lovelace Biomedical Research Institute’s 75A50126F61002 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 25, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50126F61002? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50126F61002